View Mobile Friendly Conference List »

Setting new standards in information exchange for the pharmaceutical and biotech industry


Eli Lilly Confirmed to Discuss Trial Match “Patient 2 Trial” Progress @ Dpharm Europe

  • December 1, 2014

  • We are so pleased to welcome Thomas Krohn, Director, Lilly Open Innovation, Eli Lilly to Dpharm: Disruptive Innovations to Advance Clinical Trials Europe. Tom will give the latest update and progress on the Patients 2 Consortium effort between Lilly, Pfizer and Novartis. This effort is focused on enabling patients and those who serve patients to easily pre-screen patients to clinical studies, including using their electronic medical record such as a Blue Button+ document. Through consistent, structured clinical trial eligibility criteria made available through an open API technical platform, so-called “matching services” can be enabled to streamline patient engagement and potential clinical trial participation.

    Thomas Krohn at Dpharm US 2014

    Thomas Krohn at Dpharm US 2014

    The update will include:

    • What is “P2T” or Match project
    • Where are we today and what is current focus and activity including end-user collaborations
    • What types of end-user collaborations are in place, what have we learned, and anticipated benefits to end-users
    • What are the key learnings we have had in the consortium that have helped move this project forward

    Dpharm Europe takes place in London on February 10-11, 2015.